🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison of LDL-C reductions of lerodalcibep (LIB003) 300 mg to inclisira...
Status
Completed
Location
CHU de Nantes - Hôpital Nord Laennec
Start Date
2022-06-20
Trial ID
NCT05004675
Treatments Being Tested
This randomized study is to assess LDL-C reductions at Week 12 with monthly...
Status
Recruiting
Location
Beijing Anzhen Hospital of Capital Medical University
Start Date
2024-11-16
Trial ID
NCT06568471
Treatments Being Tested
The goal of this clinical trial is to assess the LDL-Cholesterol reductions...
Status
Enrolling By Invitation
Location
Metabolic & Atherosclerosis Research Center
Start Date
2026-07-20
Trial ID
NCT07102511
Treatments Being Tested
This study is to assess LDL-C reductions at Week 52 with monthly (Q4W \[≤31...
Status
Unknown
Location
Sterling Research Group
Start Date
2021-04-22
Trial ID
NCT04806893
Treatments Being Tested
The goal is to assess the long term efficacy (LDL cholesterol reduction) an...
Status
Not Yet Recruiting
Location
G.B. Pant Institute of Postgraduate Medical Education & Research
Start Date
2027-01-20
Trial ID
NCT07775339
Treatments Being Tested
To assess the longer term safety, tolerability, and LDL C lowering efficacy...
Status
Completed
Location
Sterling Research Group
Start Date
2019-02-14
Trial ID
NCT03847974
Treatments Being Tested
Comparison of LDL-C reductions at Week 12 of monthly (Q4W\[≤ 31 days\]) dos...
Status
Completed
Location
Sterling Research Group
Start Date
2021-04-22
Trial ID
NCT04790513
Treatments Being Tested
To compare the pharmacokinetics (PK), and pharmacodynamics (PD) of single s...
Status
Completed
Location
Metabolic & Atherosclerosis Research Center (MARC)
Start Date
2022-01-28
Trial ID
NCT05234775
Treatments Being Tested
This study is to assess LDL-C reductions at Week 52 with monthly (Q4W \[≤31...
Status
Unknown
Location
Sterling Research Group
Start Date
2021-04-22
Trial ID
NCT04797247
Treatments Being Tested
This is a single-center, randomized, double-blind, placebo-controlled, sing...
Status
Enrolling By Invitation
Location
West China Hospital of Sichuan University
Start Date
2024-09-17
Trial ID
NCT06504043
Treatments Being Tested